Using Brain Imaging to Improve Spatial Targeting of Transcranial Magnetic Stimulation for Depression.

Robin F H Cash, Anne Weigand, Andrew Zalesky, Shan H Siddiqi, Jonathan Downar, Paul B Fitzgerald, Michael D Fox

November 2021 Biol Psychiatry

Synopsis of Social media discussions

The group shows cautious optimism about the article, exemplified by remarks like congratulating Robin Cash on her grant and referencing reviews on connectivity-based personalization, which demonstrate an interest in research applications. The tone is respectful and somewhat enthusiastic, emphasizing the importance of innovations in brain imaging for more effective depression treatments.

A
Agreement
 Neither agree nor disagree

The discussions are generally positive or neutral, with some recognition of the importance of the research, but no strong consensus or disagreement is evident.

I
Interest
 Moderate level of interest

Participants show mild curiosity, especially with mentions of ongoing efforts and awards that highlight the relevance of the topic.

E
Engagement
 Moderate level of engagement

Comments reflect moderate participation, such as congratulations and references to recent reviews, indicating some depth but not extensive critical analysis.

I
Impact
 Moderate level of impact

The conversations suggest an understanding of the potential significance of neuroimaging in TMS treatments and its future implications, though concrete evidence of high impact isn't widespread.

Social Mentions

YouTube

2 Videos

Facebook

2 Posts

Twitter

12 Posts

News

2 Articles

Metrics

Video Views

810

Total Likes

72

Extended Reach

35,877

Social Features

18

Timeline: Posts about article

Top Social Media Posts

Posts referencing the article

Transcranial Magnetic Stimulation for Depression: Mechanisms and Targets

Transcranial Magnetic Stimulation for Depression: Mechanisms and Targets

Transcranial Magnetic Stimulation is a neuromodulation technique approved for treating depression and other conditions, activating brain pathways to improve mood, motivation, and reduce negative emotions, with advancements enhancing targeting precision.

Dr. Pedro Beria - Psiquiatra

April 27, 2025

431 views

Enhancing Depression Treatment with Brain Imaging and TMS Targeting

Enhancing Depression Treatment with Brain Imaging and TMS Targeting

Demystifying Research McMaster

August 29, 2024

380 views

  • Kevin J. Black
    @KJBinSTL (Twitter)

    RT @leoschilbach: Using Brain Imaging to Improve Spatial Targeting of Transcranial Magnetic Stimulation for Depression - Biological Psychia…
    view full post

    March 9, 2023

    6

  • Dr. Neha Saini
    @neha_scnn (Twitter)

    RT @leoschilbach: Using Brain Imaging to Improve Spatial Targeting of Transcranial Magnetic Stimulation for Depression - Biological Psychia…
    view full post

    March 9, 2023

    6

  • jebus christoff
    @codo_nabu (Twitter)

    RT @leoschilbach: Using Brain Imaging to Improve Spatial Targeting of Transcranial Magnetic Stimulation for Depression - Biological Psychia…
    view full post

    March 8, 2023

    6

  • CopperKettle
    @Artyom_Yekat (Twitter)

    RT @leoschilbach: Using Brain Imaging to Improve Spatial Targeting of Transcranial Magnetic Stimulation for Depression - Biological Psychia…
    view full post

    March 8, 2023

    6

  • Leonhard Schilbach
    @leoschilbach (Twitter)

    RT @leoschilbach: Using Brain Imaging to Improve Spatial Targeting of Transcranial Magnetic Stimulation for Depression - Biological Psychia…
    view full post

    March 8, 2023

    6

  • priya joseph
    @ayirpelle (Twitter)

    RT @leoschilbach: Using Brain Imaging to Improve Spatial Targeting of Transcranial Magnetic Stimulation for Depression - Biological Psychia…
    view full post

    March 8, 2023

    6

  • Leonhard Schilbach
    @leoschilbach (Twitter)

    Using Brain Imaging to Improve Spatial Targeting of Transcranial Magnetic Stimulation for Depression - Biological Psychiatry https://t.co/EflM6wFlAl
    view full post

    March 8, 2023

    16

    6

  • Leonhard Schilbach
    @leoschilbach (Twitter)

    Using Brain Imaging to Improve Spatial Targeting of Transcranial Magnetic Stimulation for Depression - Biological Psychiatry https://t.co/EflM6wFlAl
    view full post

    July 3, 2021

  • Klaus Schellhorn
    @neuroconn (Twitter)

    RT @AndrewZalesky: CONGRATS to Robin Cash @cashmachine15 on award of a Young Investigator Grant from the @BBRFoundation Robin will use th…
    view full post

    September 2, 2020

    4

  • Meiling Li-李美玲
    @xiaoxiaoliu44 (Twitter)

    RT @AndrewZalesky: CONGRATS to Robin Cash @cashmachine15 on award of a Young Investigator Grant from the @BBRFoundation Robin will use th…
    view full post

    September 2, 2020

    4

  • Marcus Kaiser
    @ConnectomeLab (Twitter)

    RT @AndrewZalesky: CONGRATS to Robin Cash @cashmachine15 on award of a Young Investigator Grant from the @BBRFoundation Robin will use th…
    view full post

    September 1, 2020

    4

  • Andrew Zalesky
    @AndrewZalesky (Twitter)

    CONGRATS to Robin Cash @cashmachine15 on award of a Young Investigator Grant from the @BBRFoundation Robin will use the grant to continue work into connectivity-based personalization of TMS for depression Check out Robin's recent review on the topic: https://t.co/csiAWISfby https://t.co/6BQPseUOIh
    view full post

    September 1, 2020

    42

    4

Abstract Synopsis

  • This text explains how brain imaging techniques are helping to improve the way Transcranial Magnetic Stimulation (TMS) is targeted to treat depression, as early methods were less precise and led to variable responses.
  • Recent advances use neuroimaging to identify more specific brain regions, especially those connected to limbic areas like the subgenual cingulate cortex, which may lead to more effective and personalized TMS treatments.
  • The article discusses the potential of using brain connectivity data to find optimal TMS targets for different patients, and emphasizes the importance of future research in refining these approaches and improving clinical outcomes.]